PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CD14 9,941 Target Disease Dysmenorrhea 3,263 1 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Breast Cancer 173,695 58 0.00 -1.00 0.01 0.54
CD14 9,941 Target Target Endoglin 1,333 9 0.00 -1.00 0.01 0.62
CD14 9,941 Target Disease Leukemia 162,805 636 0.02 -0.97 0.06 0.62
CD14 9,941 Target Disease Pain 409,851 46 0.00 -1.00 0.00 0.50
CD14 9,941 Target Disease Syphilis 20,217 7 0.00 -1.00 0.00 0.54
CD14 9,941 Target Disease Gastritis 17,713 15 0.00 -1.00 0.00 0.57
CD14 9,941 Target Target DNA-damage-inducible transcript 3 30 1 0.00 -0.98 0.03 0.62
CD14 9,941 Target Disease Psoriasis 26,882 36 0.00 -1.00 0.00 0.58
CD14 9,941 Target Target BTK 1,263 3 0.00 -1.00 0.00 0.58
CD14 9,941 Target Disease Rare Diseases 2,212 1 0.00 -1.00 0.00 0.54
CD14 9,941 Target Target CXCL11 526 6 0.00 -0.99 0.01 0.62
CD14 9,941 Target Disease Itching 5,798 2 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Rheumatic Fever 6,356 1 0.00 -1.00 0.00 0.51
CD14 9,941 Target Target BMPR1A 279 1 0.00 -1.00 0.00 0.58
CD14 9,941 Target Target AGP 2,006 3 0.00 -1.00 0.00 0.57
CD14 9,941 Target Disease Diabetic Retinopathy 14,494 4 0.00 -1.00 0.00 0.53
CD14 9,941 Target Target Retinoic Acid Receptor Alpha 1,068 3 0.00 -1.00 0.00 0.59
CD14 9,941 Target Disease Irritable Bowel Syndrome 8,230 1 0.00 -1.00 0.00 0.51
CD14 9,941 Target Target C7 7,027 1 0.00 -1.00 0.00 0.51
CD14 9,941 Target Disease SIDS 3,179 2 0.00 -1.00 0.00 0.55
CD14 9,941 Target Disease Chronic Lymphocytic Leukemia 11,642 40 0.00 -1.00 0.00 0.62
CD14 9,941 Target Target Bivalirudin 891 1 0.00 -1.00 0.00 0.56
CD14 9,941 Target Disease Hyperprolactinemia 4,112 1 0.00 -1.00 0.00 0.52
CD14 9,941 Target Disease Diverticulitis 4,735 1 0.00 -1.00 0.00 0.52
CD14 9,941 Target Disease Sarcoidosis 19,176 35 0.00 -1.00 0.00 0.59
CD14 9,941 Target Target CD146 729 38 0.01 -0.97 0.05 0.68
CD14 9,941 Target Target CD154 1,512 17 0.00 -0.99 0.01 0.64
CD14 9,941 Target Target Endothelin A Receptor 722 1 0.00 -1.00 0.00 0.56
CD14 9,941 Target Target Alpha-Amylase 7,171 3 0.00 -1.00 0.00 0.54
CD14 9,941 Target Disease Heat Stroke 1,022 2 0.00 -1.00 0.00 0.57
CD14 9,941 Target Disease Relapsing Remitting Multiple Sclerosis 2,115 12 0.00 -1.00 0.01 0.62
CD14 9,941 Target Target CER 2,421 1 0.00 -1.00 0.00 0.54
CD14 9,941 Target Disease Polio 5,826 1 0.00 -1.00 0.00 0.51
CD14 9,941 Target Target BMP-7 1,112 1 0.00 -1.00 0.00 0.55
CD14 9,941 Target Disease Cryptococcosis 3,853 5 0.00 -1.00 0.00 0.57
CD14 9,941 Target Disease Allergic Rhinitis 12,280 24 0.00 -1.00 0.00 0.60
CD14 9,941 Target Disease Epilepsy 71,172 1 0.00 -1.00 0.00 0.45
CD14 9,941 Target Target APOE 12,771 17 0.00 -1.00 0.00 0.58
CD14 9,941 Target Target Eotaxin-3/CCL26 26 1 0.00 -0.98 0.04 0.62
CD14 9,941 Target Target CXCL10/IP-10 114 1 0.00 -1.00 0.01 0.60
CD14 9,941 Target Disease Rheumatoid Arthritis 78,952 249 0.01 -0.99 0.03 0.62
CD14 9,941 Target Disease Migraine 24,200 3 0.00 -1.00 0.00 0.51
CD14 9,941 Target Disease Malaria 56,215 27 0.00 -1.00 0.00 0.55
CD14 9,941 Target Target CCL3 1,427 26 0.01 -0.99 0.02 0.65
CD14 9,941 Target Disease Leishmaniasis 15,049 25 0.00 -1.00 0.00 0.59
CD14 9,941 Target Disease Leukemias 14,152 91 0.01 -0.99 0.01 0.65
CD14 9,941 Target Disease Menopause 19,680 6 0.00 -1.00 0.00 0.53
CD14 9,941 Target Target Carbonic Anhydrase 9 150 1 0.00 -1.00 0.01 0.59
CD14 9,941 Target Target Cox-2 21,583 56 0.00 -1.00 0.01 0.61